Farletuzumab Uses, Dosage, Side Effects and more

Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.

Trade Name Farletuzumab
Generic Farletuzumab
Farletuzumab Other Names Farletuzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in ovarian cancer.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share